Advanced Search
Advanced Search Results
Search results for diagnosing bribery risk
Corruption within the pharmaceutical and healthcare sectors is a matter of life and death. It has a corrosive impact on health, negatively impacting public health budgets, the price of health services and medicines, and ultimately the quality of care dispensed. Reports estimate that as much as 6% of annual global health expenditure is lost to corruption
In the past few days, we have seen two high-profile corruption stories emanating from China – the allegations against GlaxoSmithKline (GSK) and the indictment of high-profile regional governor Bo Xilai. What should we make of them?
